DARIOHEALTH CORP. — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$5M↓-31.2%
2025-09-30$5M↓-32.5%$-10M↑+15.1%-189.4%
2025-06-30$5M↓-14.2%$-13M↑+4.6%-171.4%
2025-03-31$7M↑+17.3%$-9M↓-28.6%-139.4%
2024-12-31$8M↑+110.3%
2024-09-30$7M↑+111.0%$-12M↑+21.6%-162.1%
2024-06-30$6M↑+1.7%$-14M↑+17.9%-258.8%
2024-03-31$6M↓-18.5%$-7M↑+44.1%-310.1%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$5M
↓-31.2% -$2M YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 56 quarters

margin trajectory tells the operating-leverage story
Gross Margin↓-1.7pts
53.6%
Operating Margin↓-27.4pts
-189.4%
Net Margin↓-42.9pts
-209.0%

Go deeper